| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2003;126:1134-1140
© 2003 The American Association for Thoracic Surgery
General thoracic surgery |
a Divisions of Thoracic Surgery, National Cancer Center Hospital and Research Institute, Tokyo, Japan
b Pathology, National Cancer Center Hospital and Research Institute, Tokyo, Japan
c Department of Mathematics, Tokyo University of Science, Tokyo, Japan
Received for publication August 20, 2002; revisions received October 17, 2002; revisions received October 29, 2002; accepted for publication March 13, 2003.
* Address for reprints: Hisao Asamura, MD, Division of Thoracic Surgery, National Cancer Center Hospital, 1-1, Tsukij 5-chome, Chuo-ku, Tokyo 104-0045, Japan
hasamura{at}ncc.go.jp
OBJECTIVE: This study explored the relationship between the histologic subtype of thymoma according to the new World Health Organization histologic classification and the clinical findings, as well as the prognostic significance of the classification.
METHODS: A total of 130 patients with thymoma, who underwent resection at the National Cancer Center Hospital, Tokyo, from 1962 to 2000, were studied retrospectively. The histologic subtype of thymoma was determined according to the new World Health Organization histologic classification. The stage was also determined according to a modified Masaoka's classification as stage I, II, III, IVa, or IVb. To determine the factors that may affect the prognosis of thymoma, a multivariate analysis with Cox's proportional hazards regression model was performed.
RESULTS: The distribution of histologic subtype was type A (n = 18), type AB (n = 56), type B1 (n = 15), type B2 (n = 29), and type B3 (n = 12). A close correlation was seen between the histologic subtype and stage (P = .000). The overall survivals at 5 and 10 years were 92% and 91%, respectively. The 5- and 10-year survivals according to stage were 100% and 100% (stage I, n = 40; stage II, n = 54), 81% and 76% (stage III, n = 25), and 47% and 47% (stage IV, n = 11), respectively. The difference in survival between stage III and stage IV was significant (P = .000). Patients with type A or AB thymoma demonstrated a 100% survival at both 5 and 10 years. Recurrences were seen in 12 patients with complete resection. According to a multivariate analysis, tumor size (P = .001), completeness of resection (P = .002), histologic subtype (P = .011), and stage (P = .00) were significant prognostic factors.
CONCLUSION: The World Health Organization histologic classification significantly correlated with the clinical stage. Tumor size, completeness of resection, histologic subtype, and stage predicted the prognosis of thymoma.
This article has been cited by other articles:
|
|
 |
|
  E. Davenport and R. A. Malthaner The role of surgery in the management of thymoma: a systematic review. Ann. Thorac. Surg., August 1, 2008; 86(2): 673 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huang, N. P. Rizk, W. D. Travis, V. E. Seshan, M. S. Bains, J. Dycoco, R. J. Downey, R. M. Flores, B. J. Park, and V. W. Rusch Feasibility of multimodality therapy including extended resections in stage IVA thymoma. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1477 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Detterbeck Clinical Value of the WHO Classification System of Thymoma Ann. Thorac. Surg., June 1, 2006; 81(6): 2328 - 2334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Wright, J. C. Wain, D. R. Wong, D. M. Donahue, H. A. Gaissert, H. C. Grillo, and D. J. Mathisen Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1413 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. V. Duwe, D. H. Sterman, and A. I. Musani Tumors of the Mediastinum Chest, October 1, 2005; 128(4): 2893 - 2909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zisis, D. Rontogianni, C. Tzavara, K. Stefanaki, A. Chatzimichalis, A. Loutsidis, K. Iliadis, A. Kontaxis, T. Dosios, and I. Bellenis Prognostic Factors in Thymic Epithelial Tumors Undergoing Complete Resection Ann. Thorac. Surg., September 1, 2005; 80(3): 1056 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Baldi, V. Ambrogi, D. Mineo, P. Mellone, M. Campioni, G. Citro, and T. C. Mineo Analysis of Cell Cycle Regulator Proteins in Encapsulated Thymomas Clin. Cancer Res., July 15, 2005; 11(14): 5078 - 5083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lucchi, M. C. Ambrogi, L. Duranti, F. Basolo, G. Fontanini, C. A. Angeletti, and A. Mussi Advanced Stage Thymomas and Thymic Carcinomas: Results of Multimodality Treatments Ann. Thorac. Surg., June 1, 2005; 79(6): 1840 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Kim, W. I. Yang, S. S. Choi, K. D. Kim, and K. Y. Chung Prognostic and Clinical Relevance of the World Health Organization Schema for the Classification of Thymic Epithelial Tumors: A Clinicopathologic Study of 108 Patients and Literature Review Chest, March 1, 2005; 127(3): 755 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Strobel, A. Bauer, B. Puppe, T. Kraushaar, A. Krein, K. Toyka, R. Gold, M. Semik, R. Kiefer, W. Nix, et al. Tumor Recurrence and Survival in Patients Treated for Thymomas and Thymic Squamous Cell Carcinomas: A Retrospective Analysis J. Clin. Oncol., April 15, 2004; 22(8): 1501 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Asamura, K. Nakagawa, Y. Matsuno, K. Suzuki, S.-i. Watanabe, and R. Tsuchiya Thymoma needs a new staging system Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 163 - 167. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
